BioSpace News Archive

Albany NY, United States: According to the report, the global digital dentistry materials & systems market was valued at US$ 2.9 Bn in 2020 and is projected to expand at a CAGR of 14.3% from 2021 to 2031.

The critical care therapeutics market is predicted to rise at a stellar growth rate over the forecast period from 2020 to 2030.

Diadem SpA announced release of a new peer-reviewed publication, Post-Translational Modifications of the p53 Protein and the Impact in Alzheimer’s Disease: A Review of the Literature, in the current issue of the journal Frontiers in Aging Neuroscience.

ANGLE plc, a world-leading liquid biopsy company, announces audited preliminary results for the year ended 31 December 2021.

Christine Rankin and Michael J Matly were elected as Board members at the Annual General Meeting. They replace David Colpman and Kirsten Detrick who have declined re-election.

Nortech Systems Incorporated (Nasdaq: NSYS) (the “Company”) a global leader in specialized design and manufacturing solutions for complex electrical and electromedical components, announced this week the launch of its newest active optical technology platform, Active Optical Xtreme (AOX).

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, provided an activity report for the third quarter ended March 31, 2022.

Transcenta Holding Limited announces that the abstracts of TST001 and MSB0254 have been accepted by the 2022 annual meeting of American Society of Clinical Oncology.

Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated metastatic breast and gynecological cancers, today announced two abstracts accepted for presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.

Immunicom, Inc., a clinical-stage biotechnology company developing a breakthrough technology platform for immuno-oncology, presented data from its ongoing clinical investigation, Protocol CP7-005 [NCT04004910], at the American Association for Cancer Research (AACR) Annual Conference in New Orleans.